Overview
EN ISO 5840-2:2021/A1:2025 is a key European amendment to the international standard ISO 5840-2:2021, developed under the collaboration of ISO Technical Committee ISO/TC 150 and CEN Technical Committee CEN/TC 285. This amendment, approved in March 2025, focuses on cardiovascular implants specifically related to surgically implanted cardiac valve prostheses. It provides essential updates for the design, testing, and labeling requirements crucial for ensuring the safety, performance, and reliability of heart valve substitutes used in surgical implantation.
This standard is intended for manufacturers, regulators, and healthcare professionals involved in the development, approval, and clinical use of surgical heart valve prostheses. The amendment brings clarity on terminology, technical specifications, and measurement criteria to align with the latest technological advancements and clinical needs, supporting improved patient outcomes in cardiovascular treatments.
Key Topics
-
Terminology Updates
The amendment revises and clarifies terms such as replacing "supra-annulus" with "supra-annular region," providing precise anatomical definitions to ensure consistent communication in valve design and testing.
-
Normative References and Labeling
New references include ISO/PAS 7020:2023 relating to sizing parameters of surgical valve prostheses, emphasizing requirements for valve labeling that align with patient safety and regulatory compliance.
-
Measurement and Testing Specifications
Enhanced accuracy and frequency limits for pressure and flow measurements are specified:
- Pressure measurements (ventricular, aortic) must meet a minimum accuracy of ±0.26 kPa (±2 mmHg) and an upper frequency limit of at least 30 Hz.
- Flow meters should have an equivalent upper frequency response.
These criteria ensure reliable performance testing under physiologically relevant conditions.
-
Hemodynamic Performance Assessment
The amendment updates testing protocols including beat rates, systolic durations, cardiac outputs, and differential pressures across the closed valve, reflecting hypotensive to severe hypertensive states to simulate diverse clinical scenarios.
-
Regurgitant Volume Measurement
Specifies requirements for quantifying regurgitant volume, including closing and leakage volumes, expressed both in milliliters and as a percentage of forward flow. This provides precise metrics to assess valve competence.
Applications
-
Medical Device Manufacturing
Manufacturers of cardiac valve prostheses utilize this amendment to refine design controls, validate valve performance, and develop compliant labeling practices, essential for regulatory approvals and market access in Europe and beyond.
-
Regulatory Compliance
National standards bodies in CEN member countries are mandated to adopt this amendment, ensuring harmonized regulatory requirements for surgical heart valve implants across Europe, supporting patient safety and facilitating international trade.
-
Clinical Engineering and Research
Provides a standardized framework for clinical engineers, researchers, and healthcare providers to evaluate valve substitutes' mechanical and hemodynamic properties under clinically relevant conditions, aiding in device selection and patient-specific treatment planning.
-
Quality Assurance and Testing Laboratories
Testing laboratories apply the detailed measurement accuracy, frequency response, and performance protocols to ensure heart valve devices meet stringent quality and safety benchmarks before clinical use.
Related Standards
-
EN ISO 5840-1:2021 – Covers general requirements and test methods for cardiac valve prostheses, serving as a complementary reference for surgical valve standards.
-
ISO/PAS 7020:2023 – Establishes sizing parameters and labeling requirements related to surgical valve prostheses, referenced in this amendment for detailed guidance.
-
ISO/IEC Directives Part 1 & 2 – Provides editorial and approval procedures supporting the development and maintenance of ISO standards, applicable to this amendment.
-
Other parts of ISO 5840 series – Address different types of cardiac valve prostheses such as transcatheter heart valves, essential for comprehensive standards coverage in cardiovascular implants.
Keywords: EN ISO 5840-2 amendment 2025, cardiac valve prostheses standard, surgical heart valve substitutes, cardiovascular implants, valve prosthesis testing, heart valve labeling, hemodynamic performance testing, valve regurgitation metrics, CEN standards compliance.